A hidden immune backup system could supercharge mRNA cancer vaccines
The success of mRNA vaccines against SARS-CoV-2 during the COVID-19 pandemic transformed vaccine science. Now, the same Nobel Prize winning technology is being adapted to fight cancer, with experimental mRNA vaccines already being tested against melanoma, small cell lung cancer, bladder cancer, and several other cancers. Researchers hope these vaccines…
